Predictors of HBeAg seroconversion after long-term nucleos(t)ide analogues treatment for chronic hepatitis B: a multicenter study in real clinical setting
Braz. j. infect. dis; 21 (3), 2017
ABSTRACT Aims: To evaluate the HBeAg seroconversion rate in real clinical setting and explore its predictors in long-term nucleos(t)ide analogues (NAs) treatment for chronic hepatitis B (CHB). Methods: 251 patients were recruited from January 2001 to September 2009 in four hospitals in Hebei province, ...
Alanina Transaminasa/sangre, Antivirales/administración & dosificación, Estudios de Casos y Controles, Quimioterapia Combinada, Antígenos e de la Hepatitis B/sangre, Hepatitis B Crónica/tratamiento farmacológico, Hepatitis B Crónica/enzimología, Hepatitis B Crónica/inmunología, Estudios Retrospectivos, Seroconversión/efectos de los fármacos, Factores de Tiempo, Resultado del Tratamiento